Ocular Therapeutix, Inc. (OCUL) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Ocular Therapeutix, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -8.55x | -6.98x | -4.41x | -3.04x | -81.25x | -8.08x |
| P/B Ratio | 3.47x | 4.29x | 3.91x | 6.11x | 6.05x | 16.53x |
| P/S Ratio | 43.86x | 21.21x | 6.09x | 4.20x | 12.23x | 72.26x |
| Profitability | ||||||
| Gross Margin | 87.3% | 91.2% | 91.0% | 91.2% | 89.9% | 88.0% |
| Operating Margin | -521.0% | -269.6% | -141.0% | -152.7% | -179.3% | -361.1% |
| Net Margin | -513.2% | -303.7% | -138.1% | -138.0% | -15.1% | -894.3% |
| EBITDA Margin | -482.0% | -276.4% | -113.6% | -120.2% | 5.8% | -839.5% |
| Liquidity | ||||||
| Current Ratio | 15.39x | 10.66x | 6.66x | 4.13x | 7.26x | 9.23x |
| Quick Ratio | 15.32x | 10.59x | 6.59x | 4.07x | 7.22x | 9.19x |
| Leverage | ||||||
| Debt/Equity | 0.12x | 0.24x | 0.92x | 1.82x | 0.67x | 0.77x |
YoY = year-over-year change. Source: FMP..